La nuova revisione Cochrane sui farmaci anti-amiloidi per l'Alzheimer, guidata dal direttore di Cochrane Italia Francesco Nonino, epidemiologo e neurologo dell'IRCSS Istituto delle Scienze Neurologiche di Bologna, e Edo Richards, professore di Neurologia presso la Radboud University Medical Centre in Nijmegen, Paesi Bassi, e Chair dello Scientific Advisory Group on Neurology per la European Medical Agency (EMA), è stata ripresa dalle principali testate giornalistiche a livello mondiale.

Ecco un elenco (in continuo aggiornamento) dei principali articoli:

• Cochrane News alert & Press Release
• Bakchine S, Colosimo C, Emilsson E, Jónsdóttir S E, Massacesi L, Nonino F et al. Concerns about the approval of lecanemab for Alzheimer’s disease BMJ 2025; 389 :r778 doi:10.1136/bmj.r778
• Wise J. Alzheimer’s drugs targeting amyloid do not produce clinically meaningful effects, concludes Cochrane review BMJ 2026; 393 :s719 doi:10.1136/bmj.s719

BBC News
https://www.bbc.co.uk/news/articles/cql77wlqlx7o 

Guardian
https://www.theguardian.com/society/2026/apr/16/effect-gamechanger-alzheimers-drugs-trivial-review-concludes 

Times
https://www.thetimes.com/uk/healthcare/article/alzheimers-dementia-nhs-cochrane-review-57l2dkqs6 

Bloomberg 
https://www.bloomberg.com/news/articles/2026-04-16/alzheimer-s-drugs-targeting-amyloid-don-t-help-review-finds?embedded-checkout=true 

Independent (via PA)
https://www.independent.co.uk/news/health/alzheimers-drugs-review-lecanemab-donanemab-b2958258.html 

Evening Standard (via PA)
https://www.standard.co.uk/news/health/alzheimer-national-institute-for-health-and-care-excellence-netherlands-nhs-cochrane-b1278889.html 

New York Times
https://www.independent.co.uk/news/health/alzheimers-drugs-review-lecanemab-donanemab-b2958258.html 

RTE
https://www.rte.ie/news/health/2026/0416/1568493-alzheimers-drug/ 

Daily Mail
https://www.dailymail.co.uk/health/article-15737945/Dementia-drugs-Alzheimers-dementia-not-work.html 

Sun
https://www.thesun.co.uk/health/38832005/alzheimer-drugs-fail-dementia-treatment/ 

Mirror
https://www.mirror.co.uk/news/health/alzheimers-bombshell-top-scientists-conclude-37022491 

LBC News
https://www.lbc.co.uk/article/alzheimers-wonder-drugs-dont-work-5HjdXmw_2/ 

Daily Express
https://www.express.co.uk/life-style/health/2194634/alzheimer-s-bombshell-meds-make-difference-cause-bleeding 

https://www.express.co.uk/news/uk/2194524/dementia-drugs-bombshell-cochrane-review 

Telegraph
https://www.telegraph.co.uk/health-fitness/conditions/dementia/neurologist-miracle-dementia-drugs-dont-work/ 

https://www.telegraph.co.uk/news/2026/04/16/alzheimers-wonder-drugs-do-not-work/ 

https://uk.style.yahoo.com/went-wrong-race-cure-dementia-100000634.html

Quotidiano Sanità (ITA)

https://www.quotidianosanita.it/governo-e-parlamento/alzheimer-ministero-salute-aifa-valuta-i-due-farmaci-innovativi-ma-nessun-grande-paese-europeo-li-ha-finora-rimborsati/ 

Il Manifesto (ITA)

https://ilmanifesto.it/italia-controcorrente-sui-farmaci-anti-alzheimer 

AboutPharma (ITA)

https://www.aboutpharma.com/sanita-e-politica/nonino-cochrane-italia-laifa-e-stata-coerente-troppi-rischi-ed-efficacia-modesta-per-i-farmaci-anti-alzheimer/ 

Recenti Progressi in Medicina (ITA)

https://www.recentiprogressi.it/archivio/4530/articoli/45309/ 

NeuroInfo (ITA)

https://neuroinfo.it/news/mci-o-alzheimer-precoce-una-revisione-cochrane-boccia-gli-anticorpi-anti-amiloide/ 

Non trovi il tuo articolo? Segnalalo a cochrane.italia@ausl.bologna.it

Can’t find your article? Let us know at cochrane.italia@ausl.bologna.it